Development and validation of a stability indicating assay of doxofylline by RP-HPLC: ESI-MS/MS, 1H and 13C NMR spectroscopic characterization of degradation products and process related impurities
- 14 February 2013
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 78-79, 92-99
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Development and validation of rapid HPLC method for determination of doxofylline in bulk drug and pharmaceutical dosage formsJournal of Analytical Chemistry, 2010
- A validated, stability-indicating HPTLC method for analysis of doxofyllineJPC – Journal of Planar Chromatography – Modern TLC, 2009
- Doxofylline: The next generation methylxanthineIndian Journal of Pediatrics, 2008
- Development and validation of a sensitive LC‐MS/MS method with electrospray ionization for quantitation of doxofylline in human serum: application to a clinical pharmacokinetic studyBiomedical Chromatography, 2008
- Doxofylline: A New Generation Xanthine Bronchodilator Devoid of Major Cardiovascular Adverse EffectsCurrent Medical Research and Opinion, 2001
- Solid phase extraction and high performance liquid chromatographic determination of doxophylline in plasmaBiomedical Chromatography, 1990
- Doxofylline exerts a prophylactic effect against bronchoconstriction and pleurisy induced by PAFEuropean Journal of Pharmacology, 1989
- Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonismPsychopharmacology, 1988
- On the Mechanism of Action of Theophylline and CaffeineActa Medica Scandinavica, 1985
- Adenosine receptors in the central nervous system: Relationship to the central actions of methylxanthinesLife Sciences, 1981